Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Assets (2020 - 2022)

Atea Pharmaceuticals (AVIR) has 3 years of Assets data on record, last reported at $686.6 million in Q3 2022.

  • For Q3 2022, Assets fell 18.6% year-over-year to $686.6 million; the TTM value through Sep 2022 reached $686.6 million, down 18.6%, while the annual FY2021 figure was $772.9 million, 10.51% down from the prior year.
  • Assets reached $686.6 million in Q3 2022 per AVIR's latest filing, down from $694.3 million in the prior quarter.
  • Across five years, Assets topped out at $871.5 million in Q2 2021 and bottomed at $110.1 million in Q3 2020.
  • Average Assets over 3 years is $711.2 million, with a median of $772.9 million recorded in 2021.
  • Peak YoY movement for Assets: skyrocketed 666.08% in 2021, then dropped 20.33% in 2022.
  • A 3-year view of Assets shows it stood at $863.6 million in 2020, then dropped by 10.51% to $772.9 million in 2021, then decreased by 11.17% to $686.6 million in 2022.
  • Per Business Quant database, its latest 3 readings for Assets were $686.6 million in Q3 2022, $694.3 million in Q2 2022, and $717.2 million in Q1 2022.